Page 58 - Pharma

Dr Reddy's launches antiviral drug valganciclovir

Valganciclovir tablets is the generic version of Valcyte (owned by Hoffmann-La Roche Inc)

Deutsche Beteiligungs acquires process equipment maker Pfaudler

Pfaudler, which manufactures manufacturer of glass lined as well as fluoropolymer reactors and components at nine locations globally, owns majority shares in GMM Pfaudler in India

Lonza inks collaboration pact with innovation clusters in France & Italy

The company to support small biotechnology firms in these two clusters that are developing novel therapeutics

Panacea Biotec forms research alliance with US-based Apotex

Indian firm will undertake product development and will manufacture and supply the products to Apotex

Ranbaxy receives approval for malaria drug Synriam from 7 African countries

While the company has already launched the product in Uganda, it is planning to introduce the product in other six countries towards end of January 2015

Suven Life receives five patents from four countries

The company has received two product patents from Israel, and a patent each from Japan, China and New Zealand corresponding to the new chemical entities (NCEs)

Hong Kong-based Leaders Group eyes stake in Dr Datsons

Dr Datsons officials are expected to meet the management of Leaders Group Asia Limited for finalising the terms and conditions and magnitude of investment

Gujarat pharma market grows 22.4% in November

Gujarat was followed by Chhattisgarh market at 19.6 per cent and Madhya Pradesh Market at 19.3 per cent, showed AIOCD data

Dow-Colorcon alliance launches excipient for pharma industry

Excipient, Methocel DC2, helps pharma companies to lower manufacturing costs by up to 60%, while improving tablet quality, claims the manufacturers

Cipla sells stake in Chinese JV Jiangsu Cdymax for $18.5 mn

The company has sold its stake to an affiliate of one of the other shareholders of Jiangsu

PET bottles are safe for pharmaceutical packaging: Rituraj Gupta, AIPMA

PET bottles are used for packaging pharma products across the globe and no adverse reports by medical authorities of any country have appeared, hence it is unfair to suggest that PET packaging is harm

US-based Merck buys Cubist Pharmaceuticals for $8.4 bn

Acquisition of Cubist, a global leader in antibiotics, will augment Merck's strong foundation and opportunity for growth in hospital acute care market

Ranbaxy-Sun Pharma deal receives Competition Commission's approval

As one of its preconditions for the approval, CCI has asked the companies to divest seven products, which constitute less than one percent of the combined entity's revenues in India

Zydus Cadila launches biosimilar of Adalimumab

The Drug Controller General of India has granted approval for the company's biosimilar of Adalimumab for treating rheumatoid arthritis and other auto immune disorders in India

Sanofi to buy Merck's facility in Puerto Rico

Acquisition of this formulation and packaging site will expand the global manufacturing footprint of Merial, the animal healthcare company of Sanofi

Clinical optical imaging market to reach $2 bn in 2020

Optical coherence tomography devices along with other technologies such as near-infrared spectroscopy (NIRS) and photoacoustic tomography (PAT) to drive the growth, according to Lux Research

KKR to invest in Arbor Pharmaceuticals

Significant minority stake by KKR is expected to aid growth of Arbor

Aurobindo Pharma completes the acquisition of US-based Natrol

The company had emerged as the highest bidder ($ 132.5 million) to acquire assets of Natrol under the auction process by the US Bankruptcy Court for the District of Delaware

Clariant aims to tap pharma industry with packaging solutions

The company showcases latest polymer and desiccant packaging solutions at CPhI India 2014 which can maintain drug stability and extend shelf life

EU members fault GVK Bio clinical trials, suspend marketing approvals for medicines

European Medicines Agency (EMA) is currently reviewing findings of non-compliance with good clinical practice at the GVK Biosciences' Hyderabad site